These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9378164)

  • 1. Treatment of penile intraepithelial neoplasia (PIN) with interferon alpha-2a, CO2 laser (vaporization) and 5-fluorouracil 5% (5-FU).
    Cardamakis E; Relakis K; Ginopoulos P; Korantzis A; Metalinos K; Stathopoulos E; Papathanasiou Z; Michopoulos J; Mantouvalos H; Kotoulas IG; Tzingounis V
    Eur J Gynaecol Oncol; 1997; 18(5):410-3. PubMed ID: 9378164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of men with flat (FC) or acuminata (CA) condylomata with interferon alpha-2a.
    Relakis K; Cardamakis E; Korantzis A; Metalinos K; Mantouvalos H; Papathanasiou Z; Michopoulos J; Stathopoulos E; Kotoulas IG; Tzingounis V
    Eur J Gynaecol Oncol; 1996; 17(6):529-33. PubMed ID: 8971536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cervical intraepithelial neoplasia (CIN) with interferon alpha-2a, CO2 laser (vaporization, cone) and 5-fluorouracil.
    Cardamakis E; Koumantakis E; Relakis C; Kotoulas I; Korantzis A; Mantouvalos H; Metalinos C; Stathopoulos E; Tzingounis V
    Oncol Rep; 1996 May; 3(3):531-4. PubMed ID: 21594406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of flat or accuminata condylomata of the female genital tract with interferon alpha-2 alpha.
    Relakis K; Cardamakis E; Korantzis A; Kotoulas I; Stathopoulos E; Metalinos K; Papathanasiou Z; Mantouvalos H; Tzingounis V; Koumantakis E
    Oncol Rep; 1996 Sep; 3(5):951-5. PubMed ID: 21594489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peoscopic diagnosis of flat condyloma and penile intraepithelial neoplasia. Clinical manifestation.
    Cardamakis E; Kotoulas IG; Relakis K; Metalinos K; Stathopoulos E; Diamantis A; Korantzis A; Michopoulos J; Mantouvalos C; Tzingounis V
    Gynecol Obstet Invest; 1997; 43(4):255-60. PubMed ID: 9194625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of urethral condylomata acuminata or flat condylomata with interferon-alpha 2a.
    Cardamakis E; Kotoulas IG; Metalinos K; Mantouvalos H; Relakis K; Scarpari M; Korantzis A; Papathanasiou Z
    J Urol; 1994 Dec; 152(6 Pt 1):2011-3. PubMed ID: 7966664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings.
    Aynaud O; Ionesco M; Barrasso R
    Cancer; 1994 Sep; 74(6):1762-7. PubMed ID: 8082079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
    Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
    Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a.
    Yee LK; Allegra CJ; Steinberg SM; Grem JL
    J Natl Cancer Inst; 1992 Dec; 84(23):1820-5. PubMed ID: 1433371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
    Kim J; Zhi J; Satoh H; Koss-Twardy SG; Passe SM; Patel IH; Pazdur R
    Anticancer Drugs; 1998 Sep; 9(8):689-96. PubMed ID: 9823427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study.
    Dufour P; Husseini F; Dreyfus B; Cure H; Martin C; Prevost G; Olivier JP; Dumas F; Duclos B; Olivares R; Leszler A; Bergerat JP; Audhuy B; Thill L; Oberling F
    Ann Oncol; 1996 Aug; 7(6):575-9. PubMed ID: 8879370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M
    Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
    Köhne CH; Wilke H; Hecker H; Schöffski P; Käufer C; Rauschecker H; Andreesen R; Ohl U; Lange HJ; Klaassen U
    Ann Oncol; 1995 May; 6(5):461-6. PubMed ID: 7669711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.
    Wolmark N; Bryant J; Smith R; Grem J; Allegra C; Hyams D; Atkins J; Dimitrov N; Oishi R; Prager D; Fehrenbacher L; Romond E; Colangelo L; Fisher B
    J Natl Cancer Inst; 1998 Dec; 90(23):1810-6. PubMed ID: 9839521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
    Oncology; 2000 Apr; 58(3):227-36. PubMed ID: 10765125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
    Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
    Piga A; Cascinu S; Latini L; Marcellini M; Bavosi M; Acito L; Bascioni R; Giustini L; Francini G; Pancotti A; Rossi G; Del Papa M; Carle F; Cellerino R
    Br J Cancer; 1996 Sep; 74(6):971-4. PubMed ID: 8826868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.